State AZ
Clinical Trials in Arizona
Recruiting clinical trials with at least one study location in Arizona. Data updated daily from ClinicalTrials.gov.
Top Conditions in Arizona
NCT00674388 N/A
Recruiting
The Pediatric Anesthesia Quality Improvement Project
Condition
Surgery
Enrollment
5,000,000 pts
Location
United States
Sponsor
The Society for Pediatric Anes
NCT05412927 N/A
Recruiting
AngelMed Guardian® System PMA Post Approval Study
Condition
Acute Coronary Syndrome
Enrollment
500 pts
Location
United States
Sponsor
Angel Medical Systems
NCT03547973 Phase 2
Recruiting
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Canno...
Condition
Metastatic Urothelial Cancer
Enrollment
827 pts
Location
United States, France, Germany
Sponsor
Gilead Sciences
NCT05354141 Phase 3
Recruiting
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (...
Condition
Acute Respiratory Distress Syndrome
Enrollment
970 pts
Location
United States
Sponsor
Direct Biologics, LLC
NCT06541704 Phase 3
Recruiting
A Study Investigating Subcutaneously Administered Pozelimab in Combination With ...
Condition
Age-related Macular Degeneration (AMD)
Enrollment
975 pts
Location
United States, Austria, Canada
Sponsor
Regeneron Pharmaceuticals
NCT06600321 Phase 1
Recruiting
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
Condition
Advanced Hepatocellular Carcinoma
Enrollment
158 pts
Location
United States, Italy, South Korea
Sponsor
Alnylam Pharmaceuticals
NCT05541016 Phase 2
Recruiting
De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHP...
Condition
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Enrollment
455 pts
Location
United States
Sponsor
Mayo Clinic
NCT07044336 Phase 3
Recruiting
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected End...
Condition
Endometrial Cancer
Enrollment
700 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT06078709 Phase 2
Recruiting
Preoperative Hypofractionated Radiotherapy With FOLFOX for Esophageal or Gastroe...
Condition
Clinical Stage I Esophageal Adenocarcinoma AJCC v8
Enrollment
99 pts
Location
United States
Sponsor
Mayo Clinic
NCT06690398 Phase 3
Recruiting
Multicenter Study of Lumateperone for the Treatment of Irritability Associated W...
Condition
Irritability Associated With Autism Spectrum Disorder
Enrollment
174 pts
Location
United States
Sponsor
Intra-Cellular Therapies, Inc.
NCT05826587 N/A
Recruiting
Cardiac Rehabilitation Mobile-Health Fall Risk Prevention Intervention
Condition
Cardiac Rehabilitation
Enrollment
128 pts
Location
United States
Sponsor
Mayo Clinic
NCT07173257 N/A
Recruiting
PROMs After Pancreatectomy
Condition
Pancreas Neoplasms
Enrollment
250 pts
Location
United States
Sponsor
University of Arizona
NCT06937229 Phase 3
Recruiting
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agi...
Condition
Alzheimer Disease
Enrollment
600 pts
Location
United States, Argentina, Brazil
Sponsor
Bristol-Myers Squibb
NCT03860883 N/A
Recruiting
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Sta...
Condition
Cutaneous Melanoma, Stage II
Enrollment
2,998 pts
Location
United States, Australia, Canada
Sponsor
Melanoma and Skin Cancer Trial
NCT06962995 N/A
Recruiting
Multi-Cancer Detection Observational Cohort Study
Condition
Cancer
Enrollment
500 pts
Location
United States
Sponsor
Mayo Clinic
NCT02660645 N/A
Recruiting
Blue Light Cystoscopy With Cysview® Registry
Condition
Bladder Cancer
Enrollment
4,400 pts
Location
United States
Sponsor
Photocure
NCT04647227 Phase 4
Recruiting
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
Condition
Hemophilia A With Inhibitor
Enrollment
55 pts
Location
United States
Sponsor
American Thrombosis and Hemost
NCT05641688 Phase 3
Recruiting
[18F]PI-2620 Phase 3 Histopathological Study
Condition
Alzheimer Disease
Enrollment
200 pts
Location
United States
Sponsor
Life Molecular Imaging Ltd
NCT05975983 Phase 2
Recruiting
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulm...
Condition
Idiopathic Pulmonary Fibrosis (IPF)
Enrollment
40 pts
Location
United States
Sponsor
InSilico Medicine Hong Kong Li
NCT06545942 Phase 1
Recruiting
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastati...
Condition
Advanced Solid Tumor
Enrollment
220 pts
Location
United States, Spain, United Kingdom
Sponsor
MOMA Therapeutics
NCT06368817 Phase 2
Recruiting
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Condition
Basal Ganglia Germinoma
Enrollment
240 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT07285018 Phase 2
Recruiting
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With...
Condition
Diabetic Peripheral Neuropathic Pain
Enrollment
150 pts
Location
United States, Puerto Rico
Sponsor
Eli Lilly and Company
NCT04804644 Phase 3
Recruiting
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Who...
Condition
Metastatic Lung Small Cell Carcinoma
Enrollment
200 pts
Location
United States, Canada
Sponsor
NRG Oncology
NCT05878717 Phase 2, Phase 3
Recruiting
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosi...
Condition
Systemic Sclerosis Associated Interstitial Lung Disease
Enrollment
300 pts
Location
United States, Argentina, Australia
Sponsor
GlaxoSmithKline
NCT07276581 Phase 2
Recruiting
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheum...
Condition
Rheumatoid Arthritis
Enrollment
320 pts
Location
United States, Argentina, Brazil
Sponsor
AstraZeneca